Danish Diagnostic Development A/S

Danish Diagnostic Development A/S specializes in diagnostic imaging devices, primarily portable ultrasound systems. Their product line includes cardiac ultrasound tools like the CARDIOCAM and CARDIOMD-AC, designed for point-of-care echocardiography, as well as contrast imaging systems such as the CAPIMAGE. They also produce general diagnostic ultrasound devices like the C.CAM and C.CAM-AC for abdominal and vascular imaging, and the UNICORN for specialized medical applications. These devices are engineered for flexibility and portability in clinical settings.

Danish Diagnostic Development A/S is headquartered in the United States. The company’s location in the US aligns with its regulatory focus on FDA compliance, as evidenced by its device listings and classification pathways.

Danish Diagnostic Development A/S’s devices are listed in the FDA’s 510(k) database. This registry tracks medical devices that have obtained regulatory clearance through the 510(k) pathway, which is used for demonstrating substantial equivalence to a legally marketed predicate device. Listing in this database confirms the devices’ compliance with FDA requirements for their respective classifications.

Danish Diagnostic Development A/S’s devices fall under FDA’s Class I and Class II categories. Class I devices generally pose the lowest risk and may be exempt from some regulatory controls, while Class II devices require special controls to ensure their safety and effectiveness. The classification determines the regulatory pathway, such as the 510(k) process, which the company’s devices have undergone to demonstrate compliance.